Janet Castellano Is the Best in the Business
To this today, Castellano remains heavily involved in BMS’ D&I programs. But of course, as an experienced employment law attorney, she also supports the BMS workforce in a number of other ways.
When Castellano joined the pharmaceutical giant in 2006, she began working to support the company’s manufacturing and R&D departments. Since then, her responsibilities have expanded, and she is now tasked with providing legal support to the company’s “legal think tank” as well as to finance, IT, and another business-enabling functions. These functions are the backbone of the organization, Castellano explains, and she is excited to help them thrive.
In the past two years, however, Castellano and her colleagues on the BMS team have faced bigger challenges than ever before. In 2019, the company completed the acquisition of Celgene, a major pharmaceutical company focused on the development of immunology and cancer therapies. As Castellano points out, this was the company’s largest acquisition since BMS acquired Squibb in 1989. Then, in October 2020, BMS announced that it would acquire MyoKardia, a pioneering organization exclusively focused on cardiovascular conditions, for $13 billion.